Bisphenol A at environmentally relevant doses induces cyclooxygenase-2 expression and promotes invasion of human mesenchymal stem cells derived from uterine myoma tissue

Taiwanese Journal of Obstetrics and Gynecology

Volumn 52, Issue 2, 2013, Pages 246-252

  Wang, Kai Hung ^a   Kao, An Pei ^b   Chang, Chia Cheng ^c   Lin, Ta Chin ^a   Kuo, Tsung Cheng ^a  

^a KUO GENERAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Bisphenol A; Cell invasion; Cyclooxygenase 2; Mesenchymal stem cells; Uterine myoma

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ACETYLCYSTEINE; ASCORBIC ACID 2 PHOSPHATE; CYCLOOXYGENASE 2; ENDOGLIN; ESTROGEN; OCTAMER TRANSCRIPTION FACTOR 4; THY 1 ANTIGEN;

ADIPOCYTE; ARTICLE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL INVASION; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MESENCHYMAL STEM CELL; OSTEOBLAST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT RESPONSE; UTERUS MYOMA;

BISPHENOL A; CELL INVASION; CYCLOOXYGENASE-2; MESENCHYMAL STEM CELLS; UTERINE MYOMA;

BENZHYDRYL COMPOUNDS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CYCLOOXYGENASE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL EXPOSURE; ESTROGENS, NON-STEROIDAL; FEMALE; GENE EXPRESSION; HUMANS; LEIOMYOMA; MESENCHYMAL STROMAL CELLS; NEOPLASM INVASIVENESS; PHENOLS; TUMOR CELLS, CULTURED; UTERINE NEOPLASMS;

EID: 84881023996     PISSN: 10284559     EISSN: 18756263     Source Type: Journal    
DOI: 10.1016/j.tjog.2013.04.016     Document Type: Article

References (68)

1. Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997, 3:730-737.
2. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., et al. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
3. Kim C.F., Jackson E.L., Woolfenden A.E., Lawrence S., Babar I., Vogel S., et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005, 121:823-835.
4. Fang D., Nguyen T.K., Leishear K., Finko R., Kulp A.N., Hotz S., et al. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 2005, 65:9328-9337.
5. Li C., Heidt D.G., Dalerba P., Burant C.F., Zhang L., Adsay V., et al. Identification of pancreatic cancer stem cells. Cancer Res 2007, 67:1030-1037.
6. O'Brien C.A., Pollett A., Gallinger S., Dick J.E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007, 445:106-110.
7. Collins A.T., Berry P.A., Hyde C., Stower M.J., Maitland N.J. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005, 65:10946-10951.
8. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003, 100:3983-3988.
9. Hope K.J., Jin L., Dick J.E. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat Immunol 2004, 5:738-743.
10. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003, 63:5821-5828.
11. Sell S. Alpha-fetoprotein, stem cells and cancer: how study of the production of alpha-fetoprotein during chemical hepatocarcinogenesis led to reaffirmation of the stem cell theory of cancer. Tumour Biol 2008, 29:161-180.
12. Herrera M.B., Bruno S., Buttiglieri S., Tetta C., Gatti S., Deregibus M.C., et al. Isolation and characterization of a stem cell population from adult human liver. Stem Cells 2006, 24:2840-2850.
13. McClanahan T., Koseoglu S., Smith K., Grein J., Gustafson E., Black S., et al. Identification of overexpression of orphan G protein-coupled receptor GPR49 in human colon and ovarian primary tumors. Cancer Biol Ther 2006, 5:419-426.
14. Becker L., Huang Q., Mashimo H. Immunostaining of Lgr5, an intestinal stem cell marker, in normal and premalignant human gastrointestinal tissue. ScientificWorldJournal 2008, 8:1168-1176.
15. Chang C.C. Recent translational research: stem cells as the roots of breast cancer. Breast Cancer Res 2006, 8:103.
16. Lin T., Meng L., Li Y., Tsai R.Y. Tumor-initiating function of nucleostemin-enriched mammary tumor cells. Cancer Res 2010, 70:9444-9452.
17. Stewart E.A. Uterine fibroids. Lancet 2001, 357:293-298.
18. Maruyama T., Masuda H., Ono M., Kajitani T., Yoshimura Y. Human uterine stem/progenitor cells: their possible role in uterine physiology and pathology. Reproduction 2010, 140:11-22.
19. Kao A.P., Wang K.H., Chang C.C., Lee J.N., Long C.Y., Chen H.S., et al. Comparative study of human eutopic and ectopic endometrial mesenchymal stem cells and the development of an in vivo endometriotic invasion model. Fertil Steril 2011, 95:1308-1315.
20. Hubbard S.A., Friel A.M., Kumar B., Zhang L., Rueda B.R., Gargett C.E. Evidence for cancer stem cells in human endometrial carcinoma. Cancer Res 2009, 69:8241-8248.
21. Ono M., Maruyama T., Masuda H., Kajitani T., Nagashima T., Arase T., et al. Side population in human uterine myometrium displays phenotypic and functional characteristics of myometrial stem cells. Proc Natl Acad Sci USA 2007, 104:18700-18705.
22. Chang H.L., Senaratne T.N., Zhang L., Szotek P.P., Stewart E., Dombkowski D., et al. Uterine leiomyomas exhibit fewer stem/progenitor cell characteristics when compared with corresponding normal myometrium. Reprod Sci 2010, 17:158-167.
23. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
24. Conget P.A., Minguell J.J. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol 1999, 181:67-73.
25. Lin T.M., Tsai J.L., Lin S.D., Lai C.S., Chang C.C. Accelerated growth and prolonged lifespan of adipose tissue-derived human mesenchymal stem cells in a medium using reduced calcium and antioxidants. Stem Cells Dev 2005, 14:92-102.
26. Lin T.M., Chang H.W., Wang K.H., Kao A.P., Chang C.C., Wen C.H., et al. Isolation and identification of mesenchymal stem cells from human lipoma tissue. Biochem Biophy Res Comm 2007, 361:883-889.
27. Lee O.K., Kuo T.K., Chen W.M., Lee K.D., Hsieh S.L., Chen T.H. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004, 103:1669-1675.
28. Young H.E., Steele T.A., Bray R.A., Hudson J., Floyd J.A., Hawkins K., et al. Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat Rec 2001, 264:51-62.
29. De Bari C., Dell'Accio F., Tylzanowski P., Luyten F.P. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 2001, 44:1928-1942.
30. Yen B.L., Huang H.I., Chien C.C., Jui H.Y., Ko B.S., Yao M., et al. Isolation of multipotent cells from human term placenta. Stem Cells 2005, 23:3-9.
31. Tsai M.S., Lee J.L., Chang Y.J., Hwang S.M. Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod 2004, 19:1450-1456.
32. Kassis I., Zangi L., Rivkin R., Levdansky L., Samuel S., Marx G., et al. Isolation of mesenchymal stem cells from G-CSF-mobilized human peripheral blood using fibrin microbeads. Bone Marrow Transplant 2006, 37:967-976.
33. Takeuchi T., Tsutsumi O. Serum bisphenol A concentrations showed gender differences, possibly linked to androgen levels. Biochem Biophy Res Comm 2002, 291:76-78.
34. Ikezuki Y., Tsutsumi O., Takai Y., Kamei Y., Taketani Y. Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure. Hum Reprod 2002, 17:2839-2841.
35. Ouchi K., Watanabe S. Measurement of bisphenol A in human urine using liquid chromatography with multi-channel coulometric electrochemical detection. J Chromatography. B, Anal Tech in Biomed and Life Sci 2002, 780:365-370.
36. Ye X., Kuklenyik Z., Needham L.L., Calafat A.M. Measuring environmental phenols and chlorinated organic chemicals in breast milk using automated on-line column-switching-high performance liquid chromatography-isotope dilution tandem mass spectrometry. J Chromatography. B, Anal Tech in Biomed and Life Sci 2006, 831:110-115.
37. Sasaki N., Okuda K., Kato T., Kakishima H., Okuma H., Abe K., et al. Salivary bisphenol-A levels detected by ELISA after restoration with composite resin. J Mater Sci Mater Med 2005, 16:297-300.
38. Fernandez M.F., Arrebola J.P., Taoufiki J., Navalón A., Ballesteros O., Pulgar R., et al. Bisphenol-A and chlorinated derivatives in adipose tissue of women. Reprod Toxicol 2007, 24:259-264.
39. Calafat A.M., Kuklenyik Z., Reidy J.A., Caudill S.P., Ekong J., Needham L.L. Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect 2005, 13:391-395.
40. Braun J.M., Kalkbrenner A.E., Calafat A.M., Bernert J.T., Ye X., Silva M.J., et al. Variability and predictors of urinary bisphenol A concentrations during pregnancy. Environ Health Perspect 2011, 119:131-137.
41. Sun Y., Irie M., Kishikawa N., Wada M., Kuroda N., Nakashima K. Determination of bisphenol A in human breast milk by HPLC with column-switching and fluorescence detection. Biomed Chromatogr 2004, 18:501-507.
42. Vandenberg L.N., Hauser R., Marcus M., Olea N., Welshons W.V. Human exposure to bisphenol A (BPA). Reprod Toxicol 2007, 24:139-177.
43. Welshons W.V., Nagel S.C., vom Saal F.S. Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 2006, 147:S56-S69.
44. Takeuchi T., Tsutsumi O., Ikezuki Y., Takai Y., Taketani Y. Positive relationship between androgen and the endocrine disruptor, bisphenol A, in normal women and women with ovarian dysfunction. Endocr J 2004, 51:165-169.
45. Sugiura-Ogasawara M., Ozaki Y., Sonta S., Makino T., Suzumori K. Exposure to bisphenol A is associated with recurrent miscarriage. Hum Reprod 2005, 20:2325-2329.
46. Yang M., Park M.S., Lee H.S. Endocrine disrupting chemicals: human exposure and health risks. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2006, 24:183-224.
47. Wang K.H., Kao A.P., Chang C.C., Lee J.N., Chai C.Y., Hou M.F., et al. Modulation of tumorigenesis and oestrogen receptor-alpha expression by cell culture conditions in a stem cell-derived breast epithelial cell line. Biol Cell 2010, 102:159-172.
48. - tumor stem cells, and upregulation of COX-2 and HDAC6, as major functions of HER2 in breast tumorigenesis. Mol Cancer 2010, 9:288.
49. Wang K.H., Kao A.P., Chen H.W., Wang F.Y., Chang C.H., Chang C.C., et al. Optimizing proliferation and characterization of multipotent stem cells from porcine adipose tissue. Biotech Applied Biochem 2008, 51:159-166.
50. Chang C.C., Boezi J.A., Warren S.T., Sabourin C.L., Liu P.K., Glatzer L., et al. Isolation and characterization of a UV-sensitive hypermutable aphidicolin-resistant Chinese hamster cell line. Somatic Cell Genet 1981, 7:235-253.
51. Kao A.P., Wang K.H., Long C.Y., Chai C.Y., Tsai C.F., Hsieh T.H., et al. Interleukin-1beta induces cyclooxygenase-2 expression and promotes the invasive ability of human mesenchymal stem cells derived from ovarian endometrioma. Fertil Steril 2011, 96:678-684.
52. Scholer H.R., Ruppert S., Suzuki N., Chowdhury K., Gruss P. New type of POU domain in germ line-specific protein Oct-4. Nature 1990, 344:435-439.
53. Tai M.H., Chang C.C., Kiupel M., Webster J.D., Olson L.K., Trosko J.E. Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis 2005, 26:495-502.
54. Pesce M., Scholer H.R. Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells 2001, 19:271-278.
55. Kao C.Y., Nomata K., Oakley C.S., Welsch C.W., Chang C.C. Two types of normal human breast epithelial cells derived from reduction mammaoplasty: phenotypic characterization and response to SV40 transfection. Carcinogenesis 1995, 16:531-538.
56. Neupane M., Chang C.C., Kiupel M., Yuzbasiyan-Gurkan V. Optimization of growth and differentiation of canine adipose-derived mesenchymal stem cells. Tissue Eng 2008, 14:1007-1015.
57. Wang K.H., Kao A.P., Singh S., Yu S.L., Kao L.P., Tsai Z.Y., et al. Comparative expression profiles of mRNAs and microRNAs among human mesenchymal stem cells derived from breast, face, and abdominal adipose tissues. Kaohsiung J Med Sci 2010, 26:113-122.
58. Smith J., Ladi E., Mayer-Proschel M., Noble M. Redox state is a central modulator of the balance between self-renewal and differentiation in a dividing glial precursor cell. Proc Natl Acad Sci USA 2000, 97:10032-10037.
59. De Flora S., Izzotti A., D'Agostini F., Balansky R.M. Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points. Carcinogenesis 2001, 22:999-1013.
60. Ivanov V.O., Ivanova S.V., Niedzwiecki A. Ascorbate affects proliferation of guinea-pig vascular smooth muscle cells by direct and extracellular matrix-mediated effects. J Mol Cell Cardiol 1997, 29:3293-3303.
61. Hata R., Senoo H. L-ascorbic acid 2-phosphate stimulates collagen accumulation, cell proliferation, and formation of a three-dimensional tissuelike substance by skin fibroblasts. J Cell Physiol 1989, 138:8-16.
62. Chepda T., Cadau M., Girin P., Frey J., Chamson A. Monitoring of ascorbate at a constant rate in cell culture: effect on cell growth. InVitro Cell Dev Biol Anim 2001, 37:26-30.
63. Ricupito A., Del Pozzo G., Diano N., Grano V., Portaccio M., Marino M., et al. Effect of bisphenol A with or without enzyme treatment on the proliferation and viability of MCF-7 cells. Environ Int 2009, 35:21-26.
64. Bolli A., Galluzzo P., Ascenzi P., Del Pozzo G., Manco I., Vietri M.T., et al. Laccase treatment impairs bisphenol A-induced cancer cell proliferation affecting estrogen receptor alpha-dependent rapid signals. IUBMBL Life 2008, 60:843-852.
65. Ptak A., Wrobel A., Gregoraszczuk E.L. Effect of bisphenol-A on the expression of selected genes involved in cell cycle and apoptosis in the OVCAR-3 cell line. Toxicol Lett 2011, 202:30-35.
66. Zhu H., Xiao X., Zheng J., Zheng S., Dong K., Yu Y. Growth-promoting effect of bisphenol A on neuroblastoma invitro and invivo. J Pediatr Surg 2009, 44:672-680.
67. Bouskine A., Nebout M., Brucker-Davis F., Benahmed M., Fenichel P. Low doses of bisphenol A promote human seminoma cell proliferation by activating PKA and PKG via a membrane G-protein-coupled estrogen receptor. Environ Health Perspect 2009, 117:1053-1058.
68. Dairkee S.H., Seok J., Champion S., Sayeed A., Mindrinos M., Xiao W., et al. Biphenol A induces a profile of tumor aggressiveness in high-risk cells from breast cancer patients. Cancer Res 2008, 68:2076-2080.